Hualu Wu

Zhejiang Key Laboratory Of Intelligent Cancer Biomarker Discovery And Translation
Wenzhou, 325035, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Mechanism-based inactivation of CYP2D6 by imperatorin and drug-drug interaction in vitro and in vivo.

Mechanism-based inactivation of CYP2D6 by imperatorin and drug-drug interaction in vitro and in vivo.

Journal: Archives of toxicology

Published: October 19, 2025

Simultaneous determination of iloperidone and its metabolites in rat plasma using a novel UPLC-MS/MS method: an application for drug-drug interaction.

Simultaneous determination of iloperidone and its metabolites in rat plasma using a novel UPLC-MS/MS method: an application for drug-drug interaction.

Journal: BMC pharmacology & toxicology

Published: May 10, 2025

Simultaneous Determination of Venetoclax and Posaconazole in Human Plasma by UPLC-MS/MS: Application to Therapeutic Drug Monitoring in Acute Myeloid Leukemia Patients.

Simultaneous Determination of Venetoclax and Posaconazole in Human Plasma by UPLC-MS/MS: Application to Therapeutic Drug Monitoring in Acute Myeloid Leukemia Patients.

Journal: Drug design, development and therapy

Published: April 30, 2025

Development and validation of a UPLC-MS/MS method for the quantification of parsaclisib and its application to pharmacokinetics and metabolic stability studies.

Development and validation of a UPLC-MS/MS method for the quantification of parsaclisib and its application to pharmacokinetics and metabolic stability studies.

Journal: BMC chemistry

Published: April 25, 2025

Development and Validation of a UPLC-MS/MS Detection Method of Baricitinib for Therapeutic Drug Monitoring in COVID-19 Patients.

Development and Validation of a UPLC-MS/MS Detection Method of Baricitinib for Therapeutic Drug Monitoring in COVID-19 Patients.

Journal: Drug design, development and therapy

Published: November 28, 2024

Drug Interactions of Imperatorin and Curcumin on Macitentan in vitro and in vivo.

Drug Interactions of Imperatorin and Curcumin on Macitentan in vitro and in vivo.

Journal: Drug design, development and therapy

Published: November 25, 2024

Effect of ponatinib on the metabolism of cariprazine in vitro and in vivo and the underlying mechanism.

Effect of ponatinib on the metabolism of cariprazine in vitro and in vivo and the underlying mechanism.

Journal: Toxicology and applied pharmacology

Published: November 23, 2024

Inhibitory effect of luteolin on the metabolism of vandetanib in vivo and in vitro.

Inhibitory effect of luteolin on the metabolism of vandetanib in vivo and in vitro.

Journal: Frontiers in pharmacology

Published: November 11, 2024

Corrigendum: Inhibitory effects of calcium channel blockers nisoldipine and nimodipine on ivacaftor metabolism and their underlying mechanism.

Corrigendum: Inhibitory effects of calcium channel blockers nisoldipine and nimodipine on ivacaftor metabolism and their underlying mechanism.

Journal: Frontiers in pharmacology

Published: September 13, 2024

Investigation of ponatinib metabolism and drug-drug interactions with lycopene and shikonin in vitro and invivo.

Investigation of ponatinib metabolism and drug-drug interactions with lycopene and shikonin in vitro and invivo.

Journal: Chemico-biological interactions

Published: July 16, 2024

Effects of the antitumor drugs adagrasib and asciminib on apixaban metabolism in vitro and in vivo.

Effects of the antitumor drugs adagrasib and asciminib on apixaban metabolism in vitro and in vivo.

Journal: Chemico-biological interactions

Published: April 18, 2024

Inhibitory effect of imperatorin on dabrafenib metabolism in vitro and in vivo.

Inhibitory effect of imperatorin on dabrafenib metabolism in vitro and in vivo.

Journal: Chemico-biological interactions

Published: April 09, 2024

Showing 1-12 of 18

Last Updated: 09/26/2026